Abstract
Boron neutron capture therapy (BNCT) is a promising treatment for malignant brain tumors as well as other cancers. Current research centers on both the design and synthesis of high boron containing compounds as BNCT agents, and the search for more effective delivery vehicles. This review discusses recent work on the development of nanomaterial based BNCT agents.
Keywords: Boron neutron capture therapy (BNCT), liposome, dendrimer, single-/multi-wall carbon nanotube (S/MWCNT), magnetic nanoparticle
Current Chemical Biology
Title: Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology
Volume: 1 Issue: 2
Author(s): Zhu Yinghuai, Koh Cheng Yan, John A. Maguire and Narayan S. Hosmane
Affiliation:
Keywords: Boron neutron capture therapy (BNCT), liposome, dendrimer, single-/multi-wall carbon nanotube (S/MWCNT), magnetic nanoparticle
Abstract: Boron neutron capture therapy (BNCT) is a promising treatment for malignant brain tumors as well as other cancers. Current research centers on both the design and synthesis of high boron containing compounds as BNCT agents, and the search for more effective delivery vehicles. This review discusses recent work on the development of nanomaterial based BNCT agents.
Export Options
About this article
Cite this article as:
Yinghuai Zhu, Cheng Yan Koh, Maguire A. John and Hosmane S. Narayan, Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology, Current Chemical Biology 2007; 1 (2) . https://dx.doi.org/10.2174/2212796810701020141
DOI https://dx.doi.org/10.2174/2212796810701020141 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Potential Pharmaceutical Applications of Hypericum Species
Mini-Reviews in Medicinal Chemistry A Comprehensive Study of Pharmacological Behaviors, Nano-Formulations, and Applications of Rosemary
The Natural Products Journal LRP/LR as an Alternative Promising Target in Therapy of Prion Diseases, Alzheimers Disease and Cancer
Infectious Disorders - Drug Targets Utilization of Ribozymes as Antiviral Agents
Letters in Drug Design & Discovery The Mad2-Binding Protein p31<sup>comet</sup> as a Potential Target for Human Cancer Therapy
Current Cancer Drug Targets Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening
Current Pharmaceutical Design A Natural Membrane Vesicle Exosome-based Sinomenine Delivery Platform for Hepatic Carcinoma Therapy
Current Topics in Medicinal Chemistry Design of Curcumin loaded Cellulose Nanoparticles for Prostate Cancer
Current Drug Metabolism To Die or Not to Die: That is the Autophagic Question
Current Molecular Medicine Tamoxifen and its New Derivatives in Cancer Research
Recent Patents on Anti-Cancer Drug Discovery Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology Ameliorative Effect of α-Tocopherol and Selenium on Effects of Malathion on Plasmatic Biochemical Indices and Lesions in the Liver of Rats
Current Pharmaceutical Analysis Alpha-1 Antitrypsin: It’s Role in Health and Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Advances in Diagnostic and Therapeutic Approaches for Breast Cancer: A Comprehensive Review
Current Pharmaceutical Design Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Aldose Reductase: A Multi-disease Target
Current Enzyme Inhibition Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
Current Pharmaceutical Biotechnology